MK-6186 is a novel non-nucleoside reverse transcriptase inhibitor that demonstrates sub-nanomolar activity against wild-type viruses and common NNRTI-resistant RT mutants, including K103N and Y181C. This compound exhibits significant antiviral efficacy, particularly against K103N and Y181C mutant strains. When evaluated against 12 common NNRTI-associated mutant viruses, MK-6186 shows minimal resistance, with most viral strains demonstrating fold change values below 10. In clinical virus isolates harboring NNRTI-resistant mutations, a majority exhibit significantly reduced resistance to MK-6186 compared to other treatments. This positions MK-6186 as a promising candidate for research focused on combating NNRTI-resistant HIV strains.
MK-6186 is a novel non-nucleoside reverse transcriptase inhibitor that demonstrates sub-nanomolar activity against wild-type viruses and common NNRTI-resistant RT mutants, including K103N and Y181C. This compound exhibits significant antiviral efficacy, particularly against K103N and Y181C mutant strains. When evaluated against 12 common NNRTI-associated mutant viruses, MK-6186 shows minimal resistance, with most viral strains demonstrating fold change values below 10. In clinical virus isolates harboring NNRTI-resistant mutations, a majority exhibit significantly reduced resistance to MK-6186 compared to other treatments. This positions MK-6186 as a promising candidate for research focused on combating NNRTI-resistant HIV strains.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
